Throughout April PharmaShots was swamped with the heavy traffic of life science updates. As an official media partner to Reuters Events, PharmaShots was present in Barcelona, covering groundbreaking presentations from leading biopharma companies.
Our most-read top 20 section featured reports on Top 20 RNAi Therapeutic Companies, Top 20 Biopharma Deal Terminations of 2023, and Top 20 Biopharma Companies. For our Know Your Investor section, we prepared a condensed yet illuminating report on OrbiMed Advisors.
Like every month, PharmaShots published reports on Key Biosimilars Events, FDA Approvals, and EMA Approvals along with the New Drug Designations report. Our Insights + section also featured a quarterly digest featuring the highlights of the previous quarter. For the Disease of the Month report, we covered Duchenne Muscular Dystrophy.
The Spotlight Interview: Company of the Month featured Moreno Perugini, President at Nestlé Health Science, Pharma
In May, PharmaShots Magazine is navigating Policy Reforms in Healthcare as a theme. To most of us, healthcare reforms are more like policy revamps to ensure equal, equitable, and affordable care provisions across the nation. But it is more than it meets the eye. With this Magazine, we will understand and unfold the complexities of healthcare reforms in major geographic regions.
Want to advertise in PharmaShots Magazine for FREE? Email us at connect@pharmashots.com
